Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride

Authors:

Abstract
Concerns have emerged about the adverse effects of finasteride, a drug indicated for the management of both male-pattern baldness (androgenetic alopecia)1,2 and benign prostatic hyperplasia (BPH).3-5 Reports of suicidality and psychological adverse events related to finasteride have led to coining of the term postfinasteride syndrome and the creation of organizations such as the Post-Finasteride Syndrome Foundation.6-10 In 2011, a postmarketing report was sent to the US Food and Drug Administration suggesting that finasteride may be linked to depression, self-harm, and suicide.11 In the last 5 years, health authorities in Canada, Korea, New Zealand, and the United Kingdom have also acknowledged these potential adverse effects and issued warnings for finasteride.12-15

This publication has 40 references indexed in Scilit: